biotech
biotech Articles
Gilead Sciences Inc. (NASDAQ: GILD) released third-quarter earnings report after markets closed on Tuesday. Despite negative news coming out on Tuesday with former presidential candidate Bernie...
Published:
Last Updated:
Although Gilead has been falling for about a year now, the valuation is looking more favorable — assuming Gilead is not a value trap. The earnings report will help shed some light on where the...
Published:
Last Updated:
Shares of InspireMD more than doubled in Tuesday’s session after the company announced followup data from its Paradigm-101 trial of the CGuard Embolic Prevention System.
Published:
Last Updated:
Ophthotech Corp. (NASDAQ: OPHT) is watching its shares rise in Monday’s trading session after the company reported results from its mid-stage trial of Fovista in combination with Lucentis for the...
Published:
Last Updated:
Shares of Ariad Pharmaceuticals saw a modest gain early Monday after the company announced a recent FDA decision.
Published:
Last Updated:
Genocea Biosciences shares saw a handy gain early Friday following the release of mid-stage results from its genital herpes treatment.
Published:
Last Updated:
Opexa Therapeutics Inc. (NASDAQ: OPXA) shares were in free fall Friday morning after the company reported results from its mid-stage trial for the treatment of secondary progressive multiple...
Published:
Last Updated:
Though Amgen reported better-than-expected third-quarter results on Thursday, shares sank early Friday.
Published:
Last Updated:
Biotech giant Amgen is scheduled to release its third-quarter financial results after the markets close on Thursday.
Published:
Last Updated:
Myovant Sciences entered the market near the high end of its expected price range for its initial public offering.
Published:
Last Updated:
Shares of ProQR Therapeutics jumped early on Thursday after the company announced results from its cystic fibrosis study.
Published:
Last Updated:
Biogen reported better-than-expected third-quarter financial results before the markets opened on Wednesday,
Published:
Last Updated:
The October 14 short interest data have been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Published:
Last Updated:
Myovant Sciences registered an amended Form S-1 with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price 13 million shares in...
Published:
Last Updated:
Ariad Pharmaceuticals shares were down handily on Monday after JPMorgan downgraded the stock. Also Senator Sanders recently asked about the pricing of its blood cancer drug Iclusig.
Published:
Last Updated: